Granules India has received USFDA approval for Fexofenadine Hydrochloride tablets, used to treat allergy symptoms.
The approved drug is bio-equivalent to the reference listed drug product (RLD), Allegra Allergy Tablets, 60 mg and 180 mg, of Sanofi-Aventis US LLC.
The company also received USFDA approval for Methylphenidate Hydrochloride extended-release tablets used in the treatment of a sleep disorder called narcolepsy.
Company Profile : Granules India Ltd
Leave a Reply